Antimicrobial resistance (AMR) is one of the most important modern healthcare challenges affecting our community, the healthcare sector and our environment.

 

 

Since their discovery, antibiotics have proven to be essential in the treatment of bacterial infections, reduction of complications following medical interventions, prevention of bacterial infections in dentistry, improvement of veterinary medicine and other non-therapeutic, yet important societal purposes. However, the effectiveness of antibiotics has become limited by the spread of drug-resistant bacterial strains. Antimicrobial resistance (AMR) is one of the most important modern healthcare challenges. If the problem will not be addressed, the number of deaths will increase from 700.000 per year today up to 10 million by 2050 resulting in 100 trillion USD of economic loss (O’Neill 2014). 

 In light of the rise of AMR, current actions must be substantially reinforced and new initiatives considered. EMSA, EPSA, EFPSA and EDSA partnered up by compiling this press release and presenting the current opinion of healthcare students to relevant stakeholders.